James E. Flynn, Director: Larimar Therapeutics LRMR Buy · Filed 03/02

Trade details

Type: Insider buy
Amount: $4,159,890
Shares · price: 831,978 sh · $5.00 a share
Held after: 8,153,107 sh
Stock: Larimar Therapeutics LRMR
Person: James E. FlynnDirector
Trade date: 26/02/27
Filed: 26/03/02
Days to filing: 3 days

First buy since 2023

Insiders buying this week: 13 insiders
Holding change: +11.4%

Larimar Therapeutics trades, last 26 weeks

What else happened in Larimar Therapeutics around then

Filed or reported within 30 days of the trade day · 01/28~03/29

James E. Flynn's recent trades

James E. FlynnDirector
BuyLarimar Therapeutics
Buy
Larimar Therapeutics
LRMR
$10M
2,000,000 sh
$10M
Filed 03/02
Traded 02/27
James E. FlynnDirector
BuyLarimar Therapeutics
Buy
Larimar Therapeutics
LRMR
$5.4M
1,084,012 sh
$5.4M
Filed 03/02
Traded 02/27
James E. FlynnDirector
BuyLarimar Therapeutics
Buy
Larimar Therapeutics
LRMR
$5.4M
1,084,010 sh
$5.4M
Filed 03/02
Traded 02/27
James E. FlynnDirector
SellNuvalent
Sell
Nuvalent
NUVL
$35.4M
371,287 sh
$35.4M
Filed 25/11/24
Traded 25/11/24
James E. FlynnDirector
SellNuvalent
Sell
Nuvalent
NUVL
$35.4M
371,287 sh
$35.4M
Filed 25/11/24
Traded 25/11/24

James E. Flynn, Director — bought $4.2M of Larimar Therapeutics LRMR · 831,978 sh @ $5.00 | Whalegun